| Literature DB >> 27538784 |
Valentina Colonnello1, Nicola Petrocchi2, Marina Farinelli3, Cristina Ottaviani2.
Abstract
In recent years, a growing interest has emerged in the beneficial effects of positive social interactions on health. The present work aims to review animal and human studies linking social interactions and health throughout the lifespan, with a focus on current knowledge of the possible mediating role of opioids and oxytocin. During the prenatal period, a positive social environment contributes to regulating maternal stress response and protecting the fetus from exposure to maternal active glucocorticoids. Throughout development, positive social contact with the caregiver acts as a "hidden regulator" and promotes infant neuroaffective development. Postnatal social neuroprotection interventions involving caregiver-infant physical contact seem to be crucial for rescuing preterm infants at risk for neurodevelopmental disorders. Attachment figures and friendships in adulthood continue to have a protective role for health and brain functioning, counteracting brain aging. In humans, implementation of meditative practices that promote compassionate motivation and prosocial behavior appears beneficial for health in adolescents and adults. Human and animal studies suggest the oxytocinergic and opioidergic systems are important mediators of the effects of social interactions. However, most of the studies focus on a specific phase of life (i.e., adulthood). Future studies should focus on the role of opioids and oxytocin in positive social interactions adopting a lifespan perspective. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.Entities:
Keywords: Compassion; bond; development; neuropeptides; opioid; oxytocin; social; social interactions
Mesh:
Substances:
Year: 2017 PMID: 27538784 PMCID: PMC5543675 DOI: 10.2174/1570159X14666160816120209
Source DB: PubMed Journal: Curr Neuropharmacol ISSN: 1570-159X Impact factor: 7.363
Overview of main correlates of neuroprotective factors for each developmental stage in animals (A) and humans (H).
|
|
|
|
|
|---|---|---|---|
| Gestation | • Positive social interactions for future mothers (H) | • Reduced maternal HPA stress axis activation (H) | • Positive outcomes with respect to postpartum emotional distress and infant reactivity to novelty (H) |
| Early infancy | • Skin-to-skin contact (H) | • Increased vagal tone during the neonatal period (H) | • Increased mother–infant synchrony at 3 months in preterm infants (H) |
| Youth | • Positive social experiences (A,H) | • Increased expression of BDNF (A) | • Increased emotion processing and learning (A,H) |
| Adulthood | • Companionship of partner (A) | • Enhanced oxytocin levels in the paraventricular nucleus of the hypothalamus (A) | • Decreased anxiety-like behaviors (A) |
| Elderhood | • Social support (H) | • Increased leukocyte telomere length (H) | • Reduced risk of mortality (H) |